PRGO News and Press, Perrigo Company plc From 08/05/20

Perrigo (NYSE: PRGO ) : Q2 Non-GAAP EPS of $1.03 beats by $0.16 ; GAAP EPS of $0.44 beats by $0.03 . More news on: Perrigo Company plc, Earnings news and commentary, Healthcare stocks news, Read more ...

DUBLIN , Aug. 5, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced financial results for the second quarter ended June 27, 2020. President and CEO Murray S. Kessler comment...

Perrigo (NYSE: PRGO ) declares $0.225/share quarterly dividend , in line with previous. Forward yield 1.58% Payable Sept. 15; for shareholders of record Aug. 28; ex-div Aug. 27. See PRGO Dividend Scorecard, Yield Chart, & Dividend Growth. More news on: Perrigo Company plc...

Last week, I reminded investors "stocks don't rise or fall in a straight line, so expecting some form of mean reversion is understandable," and this week, we saw high-flying NASDAQ stocks decline and lessor-loved baskets, such as industrial goods, climb. This rotation isn't too surprising,...

DUBLIN , July 15, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it will release its second quarter financial results on Wednesday, August 5, 2020 . The Company will also host a confer...

Investment Thesis Perrigo 5-year share price performance. Source: TradingView There is an argument that says the market just doesn't like pharmacy and pharmacy-servicing stocks, but a counter-argument that suggests that these companies have only themselves to blame for their depressed ...

Sol-Gel Technologies (NASDAQ: SLGL ) has entered into collaborative agreements with Perrigo Company (NYSE: PRGO ), for the development, manufacturing and commercialization of three new, generic product candidates. More news on: Sol-Gel Technologies Ltd., Perrigo Company plc, Bausch Healt...

NESS ZIONA, Israel, June 29, 2020 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that it ...

DUBLIN , June 19, 2020 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE; TASE: PRGO) today announced the closing of the previously announced registered public offering by Perrigo Finance Unlimited Company, an indirect wholly-owned finance subsidiary of Perrigo (...

Perrigo Company plc (NYSE: PRGO ) has agreed to sell  UK-based unit Rosemont Pharmaceuticals , a maker of generic medicines focused on liquid formulations, to an unnamed private equity shop for £156M (~$195M) in cash. More news on: Perrigo Company plc, Healthcare stocks news, S...